S 26308

Known as: S-26308 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1995-2001
01219952001

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2001
Review
2001
Imiquimod (S-26308, R-837) (1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4 amine), and immune response modifier, was approved as… (More)
Is this relevant?
1999
1999
Imiquimod (also known as R-837 and S-26308) is an imidazoquinoline immune response modifier and is available in the US and… (More)
Is this relevant?
Review
1999
Review
1999
Imiquimod (S-26308, R-837) (1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4 amine), an immune response modifier, demonstrates… (More)
Is this relevant?
Highly Cited
1995
Highly Cited
1995
Imiquimod (R-837, S-26308) and the analogue S-27609 were evaluated for cytokine induction in human blood cells. Both compounds… (More)
  • figure 1
  • table 1
  • table 3
  • figure 2
  • table 4
Is this relevant?